MedPath

The effects of therapeutic agents against hypertension, dyslipidemia or diabetes on cholesterol efflux capacity by HDL cholesterol

Not Applicable
Recruiting
Conditions
Hypertension, Dyslipidemia, Diabetes
Registration Number
JPRN-UMIN000005734
Lead Sponsor
Dept. of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
120
Inclusion Criteria

Not provided

Exclusion Criteria

.Patients who have allergy for taking medicine .Patients who have hepatic disorder(AST or ALT> 100IU/L), biliary duct obstruction and the following diseases with decreased hepatic function (acute hepatitis, acute exacerbation of chronic hepatitis, liver cirrhosis, liver cancer and jaundice) .eGFR<60ml/min/1.73m2 .Diabetes patients treated with insulin. .Female patients with the possibility of pregnancy .Patients excluded by doctors

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath